Ablynx

Results: 44



#Item
1

PDF Document

Add to Reading List

Source URL: www.ablynx.com

- Date: 2018-08-13 09:00:10
    2

    PDF Document

    Add to Reading List

    Source URL: www.ablynx.com

    - Date: 2018-08-13 09:00:10
      3

      PDF Document

      Add to Reading List

      Source URL: www.ablynx.com

      - Date: 2018-08-13 09:00:14
        4

        PDF Document

        Add to Reading List

        Source URL: www.ablynx.com

        - Date: 2015-02-17 11:31:01
          5

          PDF Document

          Add to Reading List

          Source URL: www.ablynx.com

          - Date: 2017-06-19 10:26:13
            6Characterization of anti-Kv1.3 Nanobodies® and activity in inflammatory model systems Veerle Delanote, Daniel Janssen, Diane Van Hoorick Ablynx nv, Zwijnaarde, Belgium Kv1.3 lead family – high affinity binding to a no

            Characterization of anti-Kv1.3 Nanobodies® and activity in inflammatory model systems Veerle Delanote, Daniel Janssen, Diane Van Hoorick Ablynx nv, Zwijnaarde, Belgium Kv1.3 lead family – high affinity binding to a no

            Add to Reading List

            Source URL: www.ablynx.com

            Language: English - Date: 2015-02-17 11:21:06
              7Formatting flexibility of Nanobodies® is ideally suited for ion channels: anti-Kv1.3 case study Daniel Janssen, Veerle Delanote, Diane Van Hoorick Ablynx nv, Zwijnaarde, Belgium ®

              Formatting flexibility of Nanobodies® is ideally suited for ion channels: anti-Kv1.3 case study Daniel Janssen, Veerle Delanote, Diane Van Hoorick Ablynx nv, Zwijnaarde, Belgium ®

              Add to Reading List

              Source URL: www.ablynx.com

              - Date: 2015-02-17 11:28:28
                8Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo,

                Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo,

                Add to Reading List

                Source URL: www.ablynx.com

                Language: English - Date: 2017-12-12 07:42:59
                  9REGULATED INFORMATION 25 May 2018 – 7:00 PM CEST NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020 GHENT, Belgium, 25 May 2018, (7:00 pm CEST) – Ablynx [Euronext Brussels and Nasdaq: ABLX] a latestage clinical

                  REGULATED INFORMATION 25 May 2018 – 7:00 PM CEST NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020 GHENT, Belgium, 25 May 2018, (7:00 pm CEST) – Ablynx [Euronext Brussels and Nasdaq: ABLX] a latestage clinical

                  Add to Reading List

                  Source URL: hugin.info

                  Language: English - Date: 2018-05-25 09:14:45
                    10NON-CLINICAL SAFETY ASSESSMENT OF ALX-0171, A NANOBODY® INTENDED FOR CLINICAL ADMINISTRATION VIA NEBULISATION Erik Depla, Koen Allosery, Veronique de Brabandere, Sofie Priem, Stefaan Rossenu* , Sandra De Boever, Eline V

                    NON-CLINICAL SAFETY ASSESSMENT OF ALX-0171, A NANOBODY® INTENDED FOR CLINICAL ADMINISTRATION VIA NEBULISATION Erik Depla, Koen Allosery, Veronique de Brabandere, Sofie Priem, Stefaan Rossenu* , Sandra De Boever, Eline V

                    Add to Reading List

                    Source URL: www.ablynx.com

                    Language: English - Date: 2015-02-17 11:32:30